arabinofuranosylcytosine triphosphate and Leukemia, Promyelocytic, Acute

arabinofuranosylcytosine triphosphate has been researched along with Leukemia, Promyelocytic, Acute in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's4 (50.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elford, HL; Fritzer-Szekeres, M; Grusch, M; Höchtl, T; Horvath, Z; Jäger, W; Krupitza, G; Salamon, A; Steinbrugger, R; Szekeres, T1
Horber, DH; Schott, H; Schwendener, RA1
Case, LD; Gregory, BW; Kucera, GL; Powell, BL; Wang, LM1
Bartimole, TM; Grant, S; Jarvis, WD; Joe, VC; Nelms, PA; Turner, AJ1
Cao, DC; Higashigawa, M; Hori, H; Ido, M; Kawasaki, H; Komada, Y; Kuwabara, H; Ohkubo, T; Sakurai, M1
Akiyama, Y; Kiriyama, Y; Kito, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A1
Akiyama, Y; Kiriyama, Y; Kitoh, T; Kubota, M; Mikawa, H; Takimoto, T; Tanizawa, A1
David, JC; Maniey, D; Marquet, J; Zittoun, J; Zittoun, R1

Trials

1 trial(s) available for arabinofuranosylcytosine triphosphate and Leukemia, Promyelocytic, Acute

ArticleYear
Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:3-4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cell Division; Child; Child, Preschool; Cytarabine; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunophenotyping; Infant; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thymidine; Tritium

1996

Other Studies

7 other study(ies) available for arabinofuranosylcytosine triphosphate and Leukemia, Promyelocytic, Acute

ArticleYear
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Biochemical pharmacology, 2002, Aug-01, Volume: 64, Issue:3

    Topics: Apoptosis; Arabinofuranosylcytosine Triphosphate; Benzamidines; Cell Division; Cytarabine; DNA; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases

2002
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    British journal of cancer, 1995, Volume: 71, Issue:5

    Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deamination; DNA; DNA, Neoplasm; Drug Resistance; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Microsomes, Liver; Tumor Cells, Cultured

1995
GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells.
    Leukemia, 1995, Volume: 9, Issue:3

    Topics: Arabinofuranosylcytosine Triphosphate; Asparaginase; Cell Division; Cytarabine; DNA, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Neoplastic Stem Cells; S Phase; Tumor Cells, Cultured; Tumor Stem Cell Assay

1995
Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.
    Oncology research, 1994, Volume: 6, Issue:2

    Topics: Alkaloids; Apoptosis; Arabinofuranosylcytosine Triphosphate; Cytarabine; DNA Damage; Drug Synergism; Gene Expression; Genes, jun; Humans; Leukemia, Promyelocytic, Acute; Protein Kinase C; Staurosporine; Tumor Cells, Cultured

1994
Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
    Advances in experimental medicine and biology, 1989, Volume: 253B

    Topics: Arabinofuranosylcytosine Triphosphate; Cycloheximide; Cytarabine; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Hypoxanthine; Hypoxanthines; Leucovorin; Leukemia, Promyelocytic, Acute; Methotrexate; Thymidine; Tumor Cells, Cultured

1989
Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines.
    Advances in experimental medicine and biology, 1989, Volume: 253B

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; Deoxycytidine; Deoxycytosine Nucleotides; Drug Synergism; Humans; Hydroxyurea; Leukemia; Leukemia, Promyelocytic, Acute; Methotrexate; Thymine Nucleotides; Tumor Cells, Cultured

1989
A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4

    Topics: Arabinofuranosylcytosine Triphosphate; Cytarabine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; DNA; DNA Ligases; DNA Polymerase II; DNA, Neoplasm; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Tumor Stem Cell Assay

1989